Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Human Chorionic Gonadotropin Therapy in Males

Primary Indications

  • The American Urological Association recommends HCG as the first-line treatment for males with hypogonadotropic hypogonadism who need testosterone restoration while preserving fertility potential 1, 3
  • For men with hypogonadotropic hypogonadism who desire fertility, HCG is preferred over exogenous testosterone which suppresses spermatogenesis 2, 4
  • HCG is specifically indicated for men with idiopathic hypogonadotropic hypogonadism to restore testosterone production and initiate spermatogenesis 1, 5

Dosing and Administration

  • The standard dosing of HCG is 500-2500 IU, administered 2-3 times weekly via subcutaneous or intramuscular injection 1
  • Initial treatment with HCG alone is used to normalize testosterone levels, followed by FSH injections when indicated for optimal sperm production 3

Secondary Indications

  • HCG may be used off-label to optimize male reproductive hormones before surgical sperm retrieval in cases of non-obstructive azoospermia, though evidence is limited 1, 6
  • HCG can be used as an alternative to testosterone therapy for men with functioning pituitary glands but low testosterone who wish to maintain fertility potential 5, 7

Important Considerations and Cautions

  • Men interested in current or future fertility should not receive exogenous testosterone as it suppresses spermatogenesis 4
  • If a patient has been on testosterone therapy, recovery of spermatogenesis after cessation may take months or rarely years 4